Is the shielding effect of cholecalciferol in SARS CoV-2 infection dependable? An evidence based unraveling.
Clin Epidemiol Glob Health
; 9: 326-331, 2021.
Article
in English
| MEDLINE | ID: covidwho-888417
ABSTRACT
Despite being announced as a global health concern and emergency in January by WHO, designing specific treatment for SARS-CoV-2 is still a summit yet to be conquered. Currently, many drugs are being tested in the clinical scenario and vitamins play a significant role in therapeutic management. Based on the available evidence, we postulate that maintaining normal vitamin D3 levels may reduce severity, mortality risk of COVID-19. This review elucidates the alarming need for randomized clinical trials to determine the role of vitamin D in patient prognosis in COVID-19 infection and on latitude bases epidemiological outcome.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Experimental Studies
/
Prognostic study
/
Randomized controlled trials
Language:
English
Journal:
Clin Epidemiol Glob Health
Year:
2021
Document Type:
Article
Affiliation country:
J.cegh.2020.10.005
Similar
MEDLINE
...
LILACS
LIS